KB Presents! - March 25 - CANCELED

Latest Advances in Alzheimer's Disease


Due to caution over the current  COVID-19 situation, the March  Kare Bears Presents is being canceled 

Kare Bears Presents had planned to host two presentations that focus on Alzheimer's and related dementias, on March 25.  We plan to invite these  speakers to make their presentations in the near future.

We are entering a new era of Alzheimer's discovery and research. Science is redefining how we look at Alzheimer's and research is blazing trails how we prevent, diagnose and treat it. Join us as we discover the latest advances in Alzheimer's research.


It is estimated that there are approximately 44 million people worldwide living with Alzheimer's disease or a related form of dementia. In the U.S. an estimated 5.5 million people of all ages have Alzheimer's disease. Of these, 5.3 million are 65 and older, and 200,000 are younger with early-onset Alzheimer's disease.

About two-thirds of Americans with Alzheimer's disease are women. This equals 3.5 million women, age 65 and up.

Brian Browne, MS CSA is the President of Dementia Care Education and the Editor-in-Chief of Dementia Care News. With more than 20 years of experience in the field of Alzheimer's disease. He is an expert in related research, clinical trials, aging, cultural competency, caregiver strategies and training. He is a noted public speaker both regionally and nationally. His research interests include examining the role of modifiable systemic risk factors and lifestyle intervention to prevent cognitive decline in Alzheimer's and other dementias.

Mr. Browne earned his undergraduate degree at Arizona State University and his graduate degree in cognitive science from Cleveland State University. His academic appointments include Midwestern as well as consulting for a number of public and private entities.

Cognitive Clinical Trials is a research and clinical trial organization. George Thomas and other team members from Cognitive Clinical Trials will be presenting information on clinical trials for Alzheimer's.

Today's clinical trials are tomorrow's miracles. Clinical trials are essential for advancing medical treatments for illnesses that need it most. Participating in a clinical trial has many benefits to you, your family, and the patient population that shares your illness now or will in the future. While each study will carry many benefits to each individual, they all have some shared benefits that make it worth looking into a study, such as:

  • Access to a team of experienced healthcare professionals every step of the way, at no cost to you
  • Free access to innovative medication or treatments that may not otherwise be available
  • Hope for a future cure
  • Advancement in treatments and cures


MARK YOUR CALENDAR FOR March 25th  at 11 am.

Eagles Nest Ballroom

Admission and Refreshments are FREE – Provided by your Kare Bears!